Takeda Chooses Belief For First Commercial Gene Therapy Tie-Up In China

Sourcing Chinese Innovation Trend Continues

A new gene therapy deal between Takeda and Belief signals multinationals are continuing to increase the pace of collaboration with Chinese partners as a source of innovation.

CSGCT PANEL DISCUSSION 20220224 Shanghai
Belief BioMed founder Xiao Xiao in a gene therapy panel discussion in March 2022 in Shanghai • Source: Brian Yang/Scrip

More from China

More from Focus On Asia